assurance maladie maternité – Baisse des tarifs des actes de biologie médicale

This written question asks about potential reductions in the fees for medical biology tests within the French health insurance system. It seeks clarification on the government's stance and plans regarding these tariffs. This concerns patients, healthcare providers, and the overall cost of medical services. The response could impact healthcare access and the financial sustainability of diagnostic services.